326 results on '"Jouneau, Stéphane"'
Search Results
2. Weight loss and outcomes in subjects with progressive pulmonary fibrosis: data from the INBUILD trial
3. Antifibrotic effects of vitamin D3 on human lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
4. Anti-fibrotic effects of nintedanib on lung fibroblasts derived from patients with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
5. Risk of Malnutrition in Patients With Systemic Sclerosis‐Associated Interstitial Lung Disease Treated With Nintedanib in the Randomized, Placebo‐Controlled SENSCIS Trial
6. SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax: Endorsed by the French Speaking Society of Respiratory Diseases (SPLF), the French Society of Emergency Medicine (SFMU), the French Intensive Care Society (SRLF), the French Society of Anesthesia & Intensive Care Medicine (SFAR) and the French Society of Thoracic and Cardiovascular Surgery (SFCTCV)
7. French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version
8. Effects of Ruxolitinib on fibrosis in preclinical models of systemic sclerosis
9. Malnutrition and decreased food intake at diagnosis are associated with hospitalization and mortality of idiopathic pulmonary fibrosis patients
10. Sacroiliac joint in sarcoidosis on computed tomography: a monocentric retrospective study (SISTER)
11. Treatment of Idiopathic Pulmonary Fibrosis with Capsule or Tablet Formulations of Pirfenidone in the Real-Life French RaDiCo-ILD Cohort
12. Tracheobronchopathia osteochondroplastica: clinical, bronchoscopic, and comorbid features in a case series
13. Chronic use of inhaled corticosteroids in patients admitted for respiratory virus infections: a 6-year prospective multicenter study
14. Usefulness of Body Composition CT Analysis in Patients with Idiopathic Pulmonary Fibrosis: A Pilot Study
15. Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial
16. Prognostic value and predictors of the alteration of the diffusing capacity of the lungs for carbon monoxide in systemic lupus erythematosus.
17. Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover
18. Disease Behaviour During the Peri-Diagnostic Period in Patients with Suspected Interstitial Lung Disease: The STARLINER Study
19. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC
20. Spondyloarthrite et sarcoïdose : faux amis ou véritable association ? Revue systématique de la littérature
21. Outpatient management of primary spontaneous pneumothorax
22. Spondyloarthritis and sarcoidosis: Related or fake friends? A systematic literature review
23. Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study
24. Exclusive ambulatory management of spontaneous pneumothorax with pigtail catheters, a prospective multicentric study
25. Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)
26. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study
27. What are the best indicators to assess malnutrition in idiopathic pulmonary fibrosis patients? A cross-sectional study in a referral center
28. Analysis of body mass index, weight loss and progression of idiopathic pulmonary fibrosis
29. Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis
30. Early detection of chronic obstructive pulmonary disease in primary care: a randomised controlled trial.
31. Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study
32. Severe hematologic complications after lung transplantation in patients with telomerase complex mutations
33. Prise en charge des exacerbations : de la ville à l’hôpital
34. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis
35. Ambulatory Management of Large Spontaneous Pneumothorax With Pigtail Catheters
36. Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Series of 47 Western Patients
37. Acute eosinophilic pneumonia following artenimol–piperaquine exposure
38. Granulometry, microbial composition and biological activity of dusts collected in French dairy farms
39. Determinants of survival after lung transplantation in telomerase-related gene mutation carriers: A retrospective cohort
40. Is it about what comes in or what goes out? A reply to Sesé et al., 2021
41. MAPK- and PKC/CREB-dependent induction of interleukin-11 by the environmental contaminant formaldehyde in human bronchial epithelial cells
42. Progressive multifocal leukoencephalopathy in a patient with silicosis
43. 131I-Labeled Lipiodol-Induced Interstitial Pneumonia: A Series of 15 Cases
44. Endoscopic Management of Idiopathic Tracheal Stenosis
45. Respiratory Conditions Associated with Tracheobronchomegaly (Mounier-Kuhn Syndrome): A Study of Seventeen Cases
46. Granulomatosis with polyangiitis: endoscopic management of tracheobronchial stenosis: results from a multicentre experience
47. Global effects of inorganic arsenic on gene expression profile in human macrophages
48. Soluble CD163 is produced by monocyte-derived and alveolar macrophages, and is not associated with the severity of idiopathic pulmonary fibrosis.
49. Incidence of Pneumocystis jiroveci Pneumonia among Groups at Risk in HIV-negative Patients
50. Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss):: Clinical Characteristics And Long-Term Followup of the 383 Patients Enrolled in the French Vasculitis Study Group Cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.